<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/09/solana-wall-street.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/09/solana-wall-street.png"/></p>
<p>羅素 2000 指數和 IWM ETF 今年上漲了 13%，全球股票持續上漲。過去五年中，該指數上漲超過 25%，但表現不及道瓊斯和納斯達克 100 等其他藍籌指數。本文探討了今年羅素指數中的一些主要漲幅股票。</p>
<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/12/Russell-2000-Index-1024x579.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/12/Russell-2000-Index-1024x579.png"/></p>
<p><em>羅素 2000 指數圖表 | 來源：TradingView</em></p>
<h2>腫瘤研究所是羅素 2000 指數中的最大贏家</h2>
<p>腫瘤研究所是一家為近 200 萬癌症患者提供服務的公司，今年在羅素 2000 指數中表現最佳，漲幅超過 1,090%。其股價最高達到 4.85 美元，比年初最低點上漲超過 2,100%。</p>
<p>該公司受益於收入增長。預計今年年收入將從去年的 3.93 億美元躍升至 5 億美元。大部分收入來自專業藥房業務，其次是服務費用和人頭費。</p>
<p>隨着美國癌症病例的持續增長，腫瘤研究所可能會繼續表現良好。</p>
<p>羅素 2000 指數中的其他主要贏家是生物技術行業的公司，如 Palvella Therapeutics、Cidara Therapeutics、Terns Pharmaceuticals、Nutex Health 和 Zenas BioPharma。這些股票今年均上漲超過 370%，因為它們在研究方面取得了進展。</p>
<h2>Planet Labs (PL)</h2>
<p>Planet Labs 是羅素 2000 指數和 IWM ETF 中表現第二好的公司，且不屬於生物技術行業。其股價今年最高達到 20.90 美元，比歷史最低點上漲了 1,098%。</p>
<p>該公司處於衞星圖像行業，在管理層宣佈強勁的收益和指引後股價大幅上漲。其最新數據顯示，第四季度的收入將在 7600 萬到 8000 萬美元之間，高於之前的指引 7350 萬美元。</p>
<p>該公司還預計年收入將在 2.97 億到 3.01 億美元之間，高於分析師的預期。這一增長髮生在公司轉向政府合同的過程中，而其商業業務仍面臨壓力。</p>
<h2>EcoStar Corporation 股票在 SpaceX IPO 前大幅上漲</h2>
<p>另一家顯著的贏家是 EchoStar，其股票今年上漲了 356%。這一增長髮生在公司與 SpaceX 繼續合作的背景下。最近，該公司與 SpaceX 達成了一項價值 26 億美元的協議。根據該協議，該公司將獲得來自 SpaceX 的 26 億美元的頻譜費用。</p>
<p>該公司與 AT&amp;T 和 SpaceX 等公司達成的頻譜交易總價值超過 400 億美元。此外，分析師預計在 SpaceX 上市後，其交易將加速。</p>
<h2>ThredUp (UP)</h2>
<p>ThredUp 是一家提供二手衣物平台的公司，是羅素 2000 指數中的另一家主要贏家，今年上漲了 332%。隨着公司在持續的通貨膨脹環境中看到更多需求，其增長加速。</p>
<p>由於投資者將其視為一個良好的轉型故事，並且其已建立起良好的輕資產轉售基礎設施，其股價也大幅上漲。然而，其股價的飆升也吸引了空頭，空頭頭寸上升至 15%，這表明一些投資者預計其將很快回落。</p>
<p>羅素 2000 指數中的其他主要贏家包括 Hecla Mining、Bloom Energy、ViaSat、Better Home &amp; Finance、US Gold、Oklo 和 SSR Mining 等公司。</p>
<p>本文《2025 年羅素 2000 指數和 IWM ETF 中的主要贏家》首次出現在 Invezz 上。</p>

回聲星通信

PVLA

CDTX

TDUP

<p>羅素 2000 指數和 IWM ETF 今年上漲了 13%，五年內增長了 25%，但仍落後於主要指數。腫瘤研究所的漲幅最大，增長超過 1090%，主要得益於收入增長。其他漲幅較大的公司包括 Planet Labs（上漲 1098%）、EchoStar（上漲 356%）和 ThredUp（上漲 332%）。生物技術行業也出現了顯著增長，像 Palvella Therapeutics 和 Cidara Therapeutics 等公司上漲超過 370%</p>

<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/09/solana-wall-street.png" alt="" original-src="https://invezz.com/wp-content/uploads/2025/09/solana-wall-street.png"/></p>
<p>The Russell 2000 Index and the IWM ETFs jumped by 13% this year as global stocks continued their uptrend. It has now risen by over 25% in the last five years, underperforming other blue-chip indices like the Dow Jones and the Nasdaq 100. This article explores some of the top gainers in the Russell Index this year.</p>
<div class="lb-trans"><p>羅素 2000 指數和 IWM ETF 今年上漲了 13%，全球股票持續上漲。過去五年中，該指數上漲超過 25%，但表現不及道瓊斯和納斯達克 100 等其他藍籌指數。本文探討了今年羅素指數中的一些主要漲幅股票。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/12/Russell-2000-Index-1024x579.png" alt="" original-src="https://invezz.com/wp-content/uploads/2025/12/Russell-2000-Index-1024x579.png"/></p>
<p><em>Russell 2000 Index chart | Source: TradingView</em></p>
<div class="lb-trans"><p><em>羅素 2000 指數圖表 | 來源：TradingView</em></p>
</div><h2>The Oncology Institute was the top gainer in the Russell 2000 Index</h2>
<div class="lb-trans"><h2>腫瘤研究所是羅素 2000 指數中的最大贏家</h2>
</div><p>The Oncology Institute, a company serving nearly 2 million cancer patients, was the best-performing company in the Russell 2000 Index this year as it jumped by over 1,090%. It rose to a high of $4.85, up by over 2,100% from the year-to-date low.</p>
<div class="lb-trans"><p>腫瘤研究所是一家為近 200 萬癌症患者提供服務的公司，今年在羅素 2000 指數中表現最佳，漲幅超過 1,090%。其股價最高達到 4.85 美元，比年初最低點上漲超過 2,100%。</p>
</div><p>The company benefited from the rising revenue growth. It estimates that its annual revenue will jump to $500 million this year from $393 million last year. Most of this revenue came from the specialty pharmacy business, followed by fee for services and capitation.</p>
<div class="lb-trans"><p>該公司受益於收入增長。預計今年年收入將從去年的 3.93 億美元躍升至 5 億美元。大部分收入來自專業藥房業務，其次是服務費用和人頭費。</p>
</div><p>The Oncology Institute will likely continue doing well as cancer cases in the United States continue growing over time.</p>
<div class="lb-trans"><p>隨着美國癌症病例的持續增長，腫瘤研究所可能會繼續表現良好。</p>
</div><p>The other top gainers in the Russell 2000 Index were companies in the biotechnology industry like Palvella Therapeutics, Cidara Therapeutics, Terns Pharmaceuticals, Nutex Health, and Zenas BioPharma. All these stocks jumped by over 370% this year as they made progress in their research.</p>
<div class="lb-trans"><p>羅素 2000 指數中的其他主要贏家是生物技術行業的公司，如 Palvella Therapeutics、Cidara Therapeutics、Terns Pharmaceuticals、Nutex Health 和 Zenas BioPharma。這些股票今年均上漲超過 370%，因為它們在研究方面取得了進展。</p>
</div><h2>Planet Labs (PL)</h2>
<div class="lb-trans"><h2>Planet Labs (PL)</h2>
</div><p>Planet Labs was the second-best-performing company in the Russell 2000 Index and the IWM ETF which is not in the biotechnology industry. Its stock jumped to a high of $20.90 this year, up by 1,098% from the all-time low.</p>
<div class="lb-trans"><p>Planet Labs 是羅素 2000 指數和 IWM ETF 中表現第二好的公司，且不屬於生物技術行業。其股價今年最高達到 20.90 美元，比歷史最低點上漲了 1,098%。</p>
</div><p>The company, which is in the satellite imagery industry, surged after the management announced strong earnings and guidance. Its most recent numbers showed that its fourth-quarter revenue will be between $76 million and $80 million, higher than the previous guidance of $73.5 million.</p>
<div class="lb-trans"><p>該公司處於衞星圖像行業，在管理層宣佈強勁的收益和指引後股價大幅上漲。其最新數據顯示，第四季度的收入將在 7600 萬到 8000 萬美元之間，高於之前的指引 7350 萬美元。</p>
</div><p>The company also expects that its annual revenue will be between $297 million and $301 million, higher than what analysts were expecting. This growth happened as the company pivoted to government contracts, with its commercial business remaining under pressure.</p>
<div class="lb-trans"><p>該公司還預計年收入將在 2.97 億到 3.01 億美元之間，高於分析師的預期。這一增長髮生在公司轉向政府合同的過程中，而其商業業務仍面臨壓力。</p>
</div><h2>EcoStar Corporation stock jumps ahead of SpaceX IPO</h2>
<div class="lb-trans"><h2>EcoStar Corporation 股票在 SpaceX IPO 前大幅上漲</h2>
</div><p>The other notable gainer was EchoStar, whose stock jumped by 356% this year. This growth happened as the company continued its partnership with SpaceX. Just recently, the company reached a $2.6 billion deal with SpaceX. Under that deal, the firm will receive $2.6 billion in fees for more spectrum from SpaceX.</p>
<div class="lb-trans"><p>另一家顯著的贏家是 EchoStar，其股票今年上漲了 356%。這一增長髮生在公司與 SpaceX 繼續合作的背景下。最近，該公司與 SpaceX 達成了一項價值 26 億美元的協議。根據該協議，該公司將獲得來自 SpaceX 的 26 億美元的頻譜費用。</p>
</div><p>The company has reached spectrum deals worth over $40 billion with companies like AT&amp;T and SpaceX. Also, analysts expect its deals will accelerate after SpaceX goes public.</p>
<div class="lb-trans"><p>該公司與 AT&amp;T 和 SpaceX 等公司達成的頻譜交易總價值超過 400 億美元。此外，分析師預計在 SpaceX 上市後，其交易將加速。</p>
</div><h2>ThredUp (UP)</h2>
<div class="lb-trans"><h2>ThredUp (UP)</h2>
</div><p>ThredUp, a company offering a platform to second-hand clothes, is another top gainer in the Russell 2000 Index as it jumped by 332% this year. Its growth accelerated as the company continued seeing more demand amid the ongoing inflationary environment.</p>
<div class="lb-trans"><p>ThredUp 是一家提供二手衣物平台的公司，是羅素 2000 指數中的另一家主要贏家，今年上漲了 332%。隨着公司在持續的通貨膨脹環境中看到更多需求，其增長加速。</p>
</div><p>The stock also jumped as investors saw it as a good turnaround story and the fact that it has established itself as a good asset-light resale infrastructure play. However, its surge has also attracted short-sellers, with its short interest rising to 15%, a sign that some investors anticipate it to retreat soon.</p>
<div class="lb-trans"><p>由於投資者將其視為一個良好的轉型故事，並且其已建立起良好的輕資產轉售基礎設施，其股價也大幅上漲。然而，其股價的飆升也吸引了空頭，空頭頭寸上升至 15%，這表明一些投資者預計其將很快回落。</p>
</div><p>The other top gainers in the Russell 2000 Index were companies like Hecla Mining, Bloom Energy, ViaSat, Better Home &amp; Finance, US Gold, Oklo, and SSR Mining.</p>
<div class="lb-trans"><p>羅素 2000 指數中的其他主要贏家包括 Hecla Mining、Bloom Energy、ViaSat、Better Home &amp; Finance、US Gold、Oklo 和 SSR Mining 等公司。</p>
</div><p>The post Top gainers in the Russell 2000 Index and IWM ETF in 2025 revealed appeared first on Invezz</p>
<div class="lb-trans"><p>本文《2025 年羅素 2000 指數和 IWM ETF 中的主要贏家》首次出現在 Invezz 上。</p>
</div>

2025 年羅素 2000 指數和 IWM ETF 的最大漲幅股揭曉